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Introduction
perforation and death [6 ] . Most patients, however, preClostridium difficile is a Gram-positive, spore-forming, sent with passage of large volumes of watery stool which toxin-producing, obligate anaerobe that is ubiquitous in experienced healthcare workers can often recognize from nature. Over the past decade, it has become a very its characteristic smell [7, 8] . A prospective caseprominent nosocomial infection worldwide. It is notable controlled study found that patients also had paralytic that C. difficile infection caused ward closures in 5% of ileus (21%), abdominal pain (22%), fever (28%) and a UK hospitals in 1993, and by 1996 this figure had risen raised white cell count (50%) [9] . Dehydration and electo 16% [1] . However, the available epidemiological data trolyte imbalance are often found and, when disease is may not be accurate. Diagnosis depends on stool culture prolonged, significant malnutrition can develop [8] . and testing for toxin, but wide variation in practices for
The incubation period for disease after exposure stool collection and in laboratory methods for diagnosis or acquisition is probably <1 week. Infection with make it difficult to know the true incidence.
C. difficile can be diagnosed up to 4 weeks after disconIt was first recognized as a potential pathogen in tinuing an implicated agent. Particularly implicated 1935 when it was described as 'Bacillus difficile' [2] . antibiotics are clindamycin, lincomycin and the cephaloHowever, its identification as a normal bowel com-sporins, although any antibiotic can cause it, including mensal and subsequent association with pseudo-those used to treat the infection (i.e. vancomycin and membranous colitis in relation to broad spectrum metronidazole). Other medications such as cytotoxic antibiotics was only established in the late 1970s [3, 4] .
Renal, oncology, haematology, geriatric, intensive which may be prolonged and difficult to control [6 ] . drugs, antacids, stool softeners and laxatives may trigger preferably flexible endoscope reveals findings depend-C. difficile-associated diarrhoea [8] . Certain procedures ent on severity of disease, and can range from normal such as nasogastric intubation, enemas and other intens-colonic mucosa, mild erythema and some oedema; ive care procedures may also predispose to it [5] standard' by many [8] , although immunoassay Management of a cohort of patients techniques are also available. ( Figure 1) .
Between January and May 1998, an outbreak of C. difficile colitis affected 25 patients in the nephrology wards at Leicester General Hospital. The presence of
Current recommendations for treatment
infection was confirmed in all cases by cytotoxin detection using tissue culture. Most patients responded to There are two broad lines of attack against C. difficile a first or second course of oral metronidazole (10-14 infection: control of bacterium and control of the days) or an additional course of oral vancomycin for precipitating antimicrobial therapy. Both are required the same duration. Other systemic antibiotics were if all truly preventable cases of C. difficile infection are discontinued as far as possible, and infection control to be avoided. The terms 'high risk' and 'low risk' policies were implemented. Symptomatic patients were antibiotics should be placed in the context of the local isolated or nursed in cohorts. patient population and the endemicity of C. difficile.
Seven patients, however, had persistent infection Limiting patient exposure to virulent C. difficile may despite sequential treatment. These patients were also be crucial. Strain differences clearly play some treated with yeast (S. boulardii ), supplied by Phillips role. For example, an epidemic clone (ribotype 1), yeast products limited, 640 mg (i.e. two tablets) three identified by Brazier and colleagues, accounts for times a day before meals. The diarrhoea resolved iñ 60% of associated isolates [7] associated with out-five patients within 5-10 days as monitored by stool breaks in the UK.
charts. Prior to therapy, all patients had an average In the UK, the Department of Health and Public of three or more episodes of loose stools per day, and Health Laboratory Service Joint Working Group a reduction to once or less daily with passage of (Clostridium difficile infection prevention and formed stools was considered as a positive response. management) has established guidelines on the treat-Of the two cases that did not respond, one had ment of initial infections, and first and second relapses multiple co-morbid factors, had difficulty complywith C. difficile. This involves a first and possibly ing with the treatment and eventually died from second course of metronidazole followed by vancomy-cardiac causes. The other had severe continuous cin if required, but there are no clear guidelines for ambulatory peritoneal dialysis (CAPD)-related fungal persistent infections [11] .
peritonitis requiring abdominal surgery and also A variety of other therapies have been proposed, eventually died. with varying protocols and results ( Table 1 ). These
Although this was not a controlled study, five out include pulsed oral and rectal vancomycin, intravenous of our worst affected patients responded promptly to metronidazole, other oral antibiotics (e.g. fusidic acid, this therapy. Previous studies [14, 16 ] have demonbacitracin, teicoplanin and rifampin), cholestyramine strated that S. boulardii has been beneficial in the as an adjuvant, and the introduction of competing, treatment of C. difficile infection, although none have non-pathogenic organisms into the intestinal tract, recruited patients with renal failure. A study carried such as Saccharomyces boulardii (as tablets, capsules out in Bristol [10] found no effect of S. boulardii in or powders), Lactobacillus acidophilus and bulgaricus prevention of antibiotic-related diarrhoea. However, given in the form of bio-yoghurts, administration of all the patients in the Bristol study were elderly, some non-toxicogenic C. difficile, and pooled faeces given as were on laxatives, all were on concurrent antibiotics enemas have all been advocated. Most of the non-and the doses of S. boulardii used were lower than antibiotic agents (biotherapy) are thought to act by those used to treat the patients reported here. re-colonizing the bowel with bacterial flora, thus displacing the C. difficile.
Conclusion
Infection with C. difficile is becoming a major cause of The role of yeast (S. boulardii ) significant morbidity and mortality in nephrology patients in the western world as broad spectrum antiThe Saccharomyces belong to the Ascomycetes fungi biotics are often required to treat infections, especially class, the most well known of which is S. cerevisiae in those on renal replacement therapy. In addition, colloquially known as brewer's yeast. The form used renal patients often have multiple co-morbid factors in the treatment of diarrhoea however is S. boulardii, which may be additional risk factors and result in and the types are differentiated based on fermentation greater disease severity and higher mortality. of various sugars. Saccharomyces boulardii has been
The ultimate aim should be prevention of spread of used extensively for many years in Europe for the infection by prompt isolation and treatment of symptotreatment of antibiotic-associated diarrhoea. Large matic patients and strict antibiotic policies. Crossnumbers of the organism can be taken safely via the infection can be avoided by thorough hand washing by oral route and do not colonize the gut permanently all attending staff after contact with patients and their [10] . The mechanism of the presumed beneficial effect environments. Daily cleaning helps to reduce the environis not fully understood, but several studies [14, 16 ] have mental load of spores [11] . Passive immunization, currently being developed, may be of some help. Vancomycin shown that S. boulardii suppresses C. difficile in the gut.
